The Pulmonary Hypertension of Sclerosing Agents is Prevented by Cyclooxygenase Inhibitors
Open Access
- 1 September 1985
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 290 (3) , 98-101
- https://doi.org/10.1097/00000441-198509000-00003
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Acute respiratory failure after sodium morrhuate esophageal sclerotherapyGastroenterology, 1983
- INCREASED LONG-TERM SURVIVAL IN VARICEAL HAEMORRHAGE USING INJECTION SCLEROTHERAPYThe Lancet, 1982
- Arachidonate raises vascular resistance but not permeability in lungs of awake sheepJournal of Applied Physiology, 1980
- Effects of Prostaglandin Cyclic Endoperoxides on the Lung Circulation of Unanesthetized SheepJournal of Clinical Investigation, 1979
- Lung vascular permeability following progressive pulmonary embolizationJournal of Applied Physiology, 1978
- Technical aspects of injection sclerotherapy of acute oesophageal variceal haemorrhage as seen by radiographyBritish Journal of Surgery, 1978
- Pulmonary Vascular Effects of Fat Emulsion Infusion in Unanesthetized SheepJournal of Clinical Investigation, 1978
- Effects of alveolar hypoxia on lung fluid and protein transport in unanesthetized sheep.Circulation Research, 1977
- Preparation of chronic lung lymph fistulas in sheepJournal of Surgical Research, 1975
- Measurement of Pulmonary EdemaCirculation Research, 1965